microrna
mirna
ie
small
ribonucleotid
act
inhibitor
protein
translat
interven
complex
network
posttranscript
mechan
fine
regul
gene
express
although
produc
intracellularli
physiolog
low
concentr
releas
circul
henc
measur
classic
biomark
howev
contrarili
latter
mirna
consid
earlier
sensit
biomark
either
physiolog
respons
patholog
process
besid
undoubt
use
number
preanalyt
analyt
postanalyt
concern
still
limit
clinic
applic
articl
aim
give
complet
overview
main
avail
knowledg
postanalyt
process
data
analysi
particularli
import
normal
strategi
circul
mirna
measur
first
hypothesi
regulatori
role
specif
rna
molecul
propos
jacob
monod
ambro
detect
caenorabd
elegan
small
singl
strand
noncod
rna
regulatori
function
gene
express
particularli
express
gene
throughout
antisens
interact
time
mirna
regulatori
system
discov
kingdom
live
world
prokaryot
protist
fungi
plant
vertebr
invertebr
anim
also
virus
impress
grow
number
research
discoveri
field
led
creation
continu
updat
databas
mirna
wwwmirbaseorg
releas
march
moment
databas
collect
mirna
entri
human
provid
univers
nomenclatur
sequenc
predict
target
gene
refer
dna
sequenc
encod
mirna
gener
locat
noncod
region
well
intron
untransl
region
utr
proteinencod
gene
canon
code
region
mirnaencod
dna
sequenc
epigenet
regul
methyl
deacetyl
mirnaencod
sequenc
transcrib
rna
polymeras
ii
primirna
cleav
premirna
nuclear
enzym
drosha
order
elimin
stem
loopflank
sequenc
premirna
export
exportin
cytoplasm
follow
action
enzym
dicer
doubl
strand
matur
mirna
releas
although
gener
one
two
strand
duplex
passeng
star
strand
gener
dicer
degrad
case
also
passeng
star
strand
act
mirna
two
mirna
gener
transcript
call
either
suffix
depend
molecular
end
origin
loop
duplex
matur
mirna
incorpor
within
rnainduc
silenc
complex
risc
togeth
argonaut
ago
protein
target
mrna
seed
region
respons
mrna
target
compris
nucleotid
posit
two
seven
doubl
strand
rna
rais
interact
mirna
target
mrna
degrad
henc
translat
inhibit
thank
nonstring
complementar
short
length
seed
region
mirna
target
sever
hundr
mrna
fig
mirnadepend
regul
gene
express
key
physiolog
role
demonstr
fact
mice
knockout
lethal
earli
embryo
essenti
embryolog
develop
human
sever
mirna
show
celltissuerestrict
express
profil
mani
other
wide
express
recent
atla
illustr
mirna
express
profil
differ
tissu
moreov
accord
investig
mirna
present
differ
bodi
fluid
also
rel
abund
serum
plasma
henc
sever
research
investig
possibl
use
biomark
inde
abnorm
express
either
singl
mirna
group
mirna
demonstr
sever
disord
includ
limit
tumor
cardiovascular
diseas
inflammatoryautoimmun
diseas
gener
case
tumor
mirna
downregul
sinc
inhibitor
gene
express
compar
nontumor
counterpart
mirna
mark
specif
neoplasia
parallel
chang
cell
andor
circul
mirna
mark
cellular
respons
physiolog
stimuli
musculoskelet
myocardi
respons
physic
activ
mirnom
great
diagnost
potenti
sinc
may
specif
diseas
physiolog
chang
henc
futur
implement
mirna
analysi
routin
set
acknowledg
howev
implement
requir
huge
effort
term
optim
harmon
preanalyt
analyt
postanalyt
phase
order
defin
biomark
molecul
might
satisfi
follow
criteria
measur
specif
clinic
set
valid
multipl
studi
direct
impact
medic
decis
figur
biogenesi
function
mirna
mirna
gene
transcrib
noncod
interor
intragen
region
rna
transcript
transcript
mediat
rna
polymeras
ii
give
rise
long
primirna
process
complex
form
nucleotidelong
precursor
mirna
premirna
mediat
export
premirna
cytoplasm
process
ribonucleas
dicer
trim
premirna
form
nucleotidelong
matur
mirna
guid
strand
incorpor
risc
involv
dicer
enzym
target
mrna
caus
repress
translat
andor
degrad
figur
produc
use
servier
medic
art
avail
http
smartserviercom
case
mirna
criterion
measur
satisfi
inde
state
detect
situ
biofluid
widen
clinic
applic
contrari
valid
impact
medic
decis
still
affect
sever
issu
mainli
deriv
inconsist
data
among
differ
studi
turn
due
lack
standard
preanalyt
eg
choic
sampl
matrix
sampl
handl
storag
lifestyl
factor
analyt
eg
low
concord
differ
platform
platform
migrat
earli
discoveri
final
commerci
postanalyt
phase
eg
sever
data
analysi
softwar
base
differ
algorithm
differ
normal
strategi
big
issu
repres
exist
sever
normal
strategi
mirna
level
biofluid
express
rel
express
valu
rather
absolut
count
per
volum
henc
use
differ
normal
strategi
differ
result
sometim
even
definit
inconsist
aris
compar
data
among
differ
lab
also
among
differ
studi
lab
thu
serious
limit
due
lack
consensu
whether
priori
defin
refer
gene
might
use
normal
data
import
standard
method
mirna
determin
huge
scientif
interest
around
class
molecul
enorm
research
effort
spent
investig
order
give
idea
topic
subject
suffici
look
pubm
trivial
type
term
mirna
record
display
publish
sinc
today
today
behind
interest
definit
biolog
role
obvious
interest
around
potenti
clinic
implement
next
futur
possibl
implement
illustr
exampl
report
field
infecti
diseas
exampl
novel
oligonucleotid
antimirna
miravirsen
shown
safe
well
toler
hcvinfect
patient
phase
iia
trial
alreadi
phase
iib
trial
suggest
mirnabas
treatment
may
well
becom
realiti
viral
vaccin
attenu
incorpor
mirna
target
sequenc
preclin
stage
mirna
biomark
infect
hold
promis
field
metabol
diseas
specif
osteoporosi
sever
mirna
associ
fractur
risk
bone
miner
densiti
bmd
nine
mirna
found
upregul
serum
patient
osteoporosi
six
mirna
upregul
bone
tissu
osteoporot
patient
among
five
mirna
upregul
serum
bone
tissu
identifi
marker
osteoporot
fractur
ageindepend
associ
osteoporot
bone
fractur
serum
crosslap
ctxi
concentr
neg
associ
bmd
osteoporot
patient
greatest
progress
mirnabiomark
discoveri
done
oncolog
cardiolog
random
phase
ii
studi
androgen
depriv
combin
cixutumumab
versu
androgen
depriv
alon
patient
new
metastat
hormonesensit
prostat
cancer
baselin
plasma
level
associ
baselin
circul
tumor
cell
count
baselin
also
associ
trial
endpoint
prostatespecif
antigen
psa
respons
furthermor
lin
et
al
demonstr
phase
ii
studi
castrationresist
prostat
cancer
patient
higher
baselin
level
mirna
belong
famili
associ
shorter
overal
surviv
studi
explor
mirna
predict
biomark
efficaci
peptid
vaccin
alon
phase
combin
chemotherapi
phase
ii
colorect
cancer
neg
associ
overal
surviv
predict
valu
mirna
tumor
cell
infiltr
immun
cell
efficaci
radiotherapi
combin
either
cddpcrtx
mitomycin
c
local
advanc
head
neck
squamou
cell
carcinoma
evalu
phase
iii
trial
highlight
potenti
marker
person
treatment
select
two
standard
regimen
chemoradi
larg
multicent
studi
investig
effect
ad
bevacizumab
standard
chemotherapi
patient
diagnos
epitheli
ovarian
cancer
low
level
trna
significantli
associ
better
surviv
level
seem
predict
effect
treatment
bevacizumab
phase
ii
clinic
trial
investig
effect
eribulin
treatment
metastat
soft
tissu
sarcoma
specif
mirna
predict
respons
mirna
assess
paraffinembed
section
phase
ii
studi
gagez
colleagu
found
predict
effici
rituximabmedi
lymphodeplet
chronic
lymphocyt
leukemia
patient
clinic
trial
base
wholegenom
mirna
sequenc
rna
extract
whole
blood
patient
nonstseg
elev
acut
coronari
syndrom
chronic
heartfailur
associ
lower
circul
level
increas
acut
coronari
event
risk
score
invers
correl
level
posit
correl
level
hand
xiao
et
al
demonstr
significantli
lower
patient
acut
heart
failur
associ
caus
mortal
patient
import
issu
concern
use
mirna
biomark
repres
sensit
specif
profil
diagnost
applic
sensit
specif
two
key
paramet
use
defin
valid
biomark
specif
diagnos
condit
confirm
presenc
diseas
also
rule
diseas
healthi
subject
two
paramet
invers
correl
plot
sensit
versu
graph
call
receiv
oper
characterist
roc
curv
repres
effect
measur
accuraci
specif
biomark
sever
studi
focus
potenti
clinic
role
mirna
diagnosi
patholog
defin
paramet
sensibl
specif
exampl
et
al
report
select
panel
seven
peripher
blood
mononuclear
cell
pbmc
deriv
mirna
indic
biomark
earli
detect
nonsmal
cell
lung
cancer
nslc
yield
sensit
specif
respect
identifi
nslc
furthermor
two
mirna
could
use
earli
diagnosi
squamou
cell
lung
carcinoma
scc
major
type
nsclc
sensit
specif
studi
lu
et
al
plasma
deriv
identifi
potenti
biomark
oral
cancer
sensit
specif
classic
biomark
combin
multipl
mirna
combin
mirna
protein
biomark
may
increas
sensit
specif
diagnosi
predict
studi
condit
support
notion
xiong
cowork
recent
identifi
panel
nine
mirna
allow
earli
detect
breast
cancer
high
diagnost
accuraci
sensit
specif
seelig
et
al
identifi
set
nine
mirna
significantli
upregul
serum
six
mirna
significantli
upregul
bone
tissu
patient
osteoporosi
fractur
compar
patient
nonosteoporot
fractur
five
mirna
upregul
serum
bone
tissu
select
mirna
could
use
biomark
diagnost
purpos
osteoporosi
combin
mirna
protein
biomark
also
investig
improv
differenti
diagnosi
pancreat
cancer
gastrointestin
cancer
benign
pancreat
diseas
bpd
yuan
colleagu
demonstr
combin
macrophag
inhibitori
perform
better
term
specif
sensit
accuraci
detect
pancreat
cancer
benign
pancreat
diseas
compar
alon
addit
cheng
et
al
test
potenti
biomark
colorect
cancer
found
high
level
circul
associ
stage
iv
colorect
cancer
author
demonstr
combin
carcinoembryon
antigen
cea
wide
use
marker
colorect
cancer
identifi
addit
stage
iv
case
train
cohort
indic
combin
two
biomark
improv
accuraci
stage
colorect
cancer
distant
metastasi
furthermor
high
level
plasma
alon
associ
poor
prognosi
altogeth
exampl
demonstr
use
panel
mirna
associ
specif
mirna
classic
protein
biomark
significantli
increas
accuraci
diagnosi
rtqpcr
revers
transcript
quantit
polymeras
chain
reaction
wide
use
method
quantifi
differ
express
profil
target
gene
techniqu
choic
due
high
sensit
specif
reproduc
howev
sampl
collect
prepar
rna
extract
differ
reversetranscript
pcr
effici
introduc
mani
technic
variabl
experiment
step
affect
quantif
lead
alter
result
import
choos
accur
normal
method
reduc
error
data
normal
mathemat
process
rank
set
candid
gene
accord
express
stabil
specif
sampl
set
specif
experiment
design
normal
need
reduc
analyt
variabl
obtain
reliabl
reproduc
biolog
result
yet
normal
still
remain
one
import
difficult
problem
associ
qpcr
analysi
gold
standard
rtqpcr
data
normal
base
use
housekeep
hk
gene
also
refer
refer
gene
express
level
ideal
intern
control
remain
constant
independ
tissu
origin
state
diseas
stage
cellcycl
stage
develop
also
remain
constant
experiment
condit
experiment
group
gener
hk
gene
constitut
gene
involv
mainten
cellular
function
express
ubiquit
cell
type
physiolog
patholog
condit
among
commonli
use
human
hk
gene
rtqpcr
normal
gene
encod
compon
cytoskeleton
bactin
compon
major
histocompat
complex
gene
involv
glycolyt
pathway
dehydrogenas
gapdh
phosphoglycer
metabol
pathway
hypoxanthin
phosphoribosyltransferas
hprt
hydroxymethylbilan
synthas
hmb
protein
fold
cyclophilin
cypa
ppia
peptidylprolyl
isomeras
b
ppib
synthesi
ribosom
unit
rrna
ribosom
protein
larg
subunit
importantli
intern
refer
gene
subject
prepar
step
gene
interest
thu
coamplif
refer
gene
sampl
prepar
target
gene
allow
minim
variat
due
differ
amount
qualiti
rna
obtain
rna
isol
differ
enzymat
effici
revers
transcript
qpcr
sampl
latest
year
howev
emerg
evid
mani
commonli
use
refer
gene
constantli
express
everi
tissu
everi
environment
circumst
report
gapdh
bactin
two
wide
use
hk
gene
vari
express
accord
differ
tissu
type
development
stage
cell
cultur
condit
cancer
type
schmittgen
cowork
demonstr
express
level
bactin
gapdh
affect
cultur
condit
show
ninefold
increas
express
level
cell
cultur
serum
compar
starv
cell
also
cell
growth
hypox
condit
demonstr
modul
express
level
certain
commonli
use
refer
gene
zhong
et
al
show
gapdh
bactin
cyclophilin
gene
express
affect
hypoxia
normal
tumor
cell
line
compar
normoxia
wherea
express
level
refer
gene
rrna
constant
condit
addit
alway
context
cell
cultur
bactin
express
shown
strongli
affect
matrigel
inhibit
dosedepend
way
condit
rrna
express
affect
thu
accord
author
repres
suitabl
refer
gene
specif
experiment
condit
gapdh
bactin
found
twofold
upregul
invas
melanoma
cell
compar
noninvas
cell
show
express
stabl
cancer
dydensborg
et
al
suggest
suitabl
refer
gene
compar
human
colon
primari
carcinoma
normal
colon
mucosa
studi
differenti
process
human
intestin
epithelium
respect
wherea
de
kok
et
al
compar
express
pattern
frequent
use
refer
gene
normal
tumor
sampl
span
colorect
bladder
skin
tumor
identifi
hprt
singl
best
refer
gene
normal
futur
cancer
studi
consid
howev
hprt
express
level
rel
low
thu
refer
gene
suitabl
normal
lowli
express
target
gene
contrari
highli
express
target
gene
recommend
choos
refer
gene
compar
express
level
usual
bactin
normal
choic
highli
express
target
howev
consid
variat
express
accord
experiment
set
use
highthroughput
gene
express
analysi
rtqpcr
identifi
biomark
measur
alter
either
physiolog
patholog
condit
increas
peripher
blood
conveni
sourc
detect
biomark
howev
gene
express
analys
whole
blood
limit
lack
standard
normal
process
particularli
difficult
cellular
composit
peripher
blood
chang
physiolog
even
patholog
condit
cancer
infect
autoimmun
diseas
nonhomogen
tissu
sampl
compos
differ
cell
type
analyz
refer
gene
choic
stabli
express
constitu
cell
type
thu
identif
suitabl
refer
gene
whole
blood
take
account
also
differ
cell
popul
may
differ
express
refer
gene
choic
addit
analyz
gene
express
peripher
blood
detect
biomark
discrimin
whole
blood
pbmcderiv
rna
differ
cell
popul
pbmc
isol
peripher
blood
gradient
separ
mainli
repres
tcell
bcell
nk
cell
monocyt
whole
blood
includ
also
neutrophil
basophil
eosinophil
granulocyt
red
blood
cell
far
common
univoc
refer
gene
exist
normal
rtqpcr
data
blood
sampl
sever
group
tri
give
indic
fit
refer
gene
specif
experiment
group
contest
dheda
cowork
analyz
hk
gene
pbmc
peripher
whole
blood
sampl
deriv
either
healthi
subject
individu
affect
tuberculosi
author
identifi
human
acid
ribosom
protein
hupo
stabl
refer
gene
whole
blood
sampl
gapdh
bactin
hprt
variabl
maximum
variabl
pbmc
stabl
gene
hupo
hprt
gapdh
bactin
elong
factor
highli
variabl
maxim
variabl
conclud
compar
whole
blood
pbmc
sampl
patient
affect
pulmonari
tuberculosi
appropri
refer
gene
hupo
obtain
reliabl
result
one
refer
gene
might
use
normal
analyz
rtqpcr
data
geometr
mean
express
multipl
refer
gene
prefer
arithmet
mean
last
decad
sever
softwar
develop
determin
stabl
reliabl
refer
gene
among
subset
gene
calcul
normal
factor
differ
statist
algorithm
among
frequent
use
genorm
normfind
bestkeep
algorithm
led
identif
singl
refer
gene
sampl
whole
blood
pbmc
subject
affect
chronic
fatigu
syndrom
healthi
control
normfind
genorm
analysi
author
identifi
ppib
stabl
refer
gene
whole
blood
sampl
best
refer
gene
pbmc
howev
stabl
optim
normal
compar
result
whole
blood
pbmc
togeth
convers
mani
author
advis
falkenberg
coauthor
demonstr
use
singl
refer
gene
suffici
stabl
select
rather
use
multipl
refer
gene
similarli
oturai
colleagu
identifi
suitabl
refer
gene
use
differ
peripher
blood
cell
popul
whole
blood
cell
pbmc
pbmcderiv
subset
cell
cell
cell
nk
cell
monocyt
b
cell
dendrit
cell
obtain
healthi
subject
patient
affect
multipl
sclerosi
ms
interferon
b
ifnb
treat
ms
patient
eight
candid
refer
gene
author
identifi
ubiquitinconjug
enzym
best
candid
normal
sampl
control
ms
subject
cell
subset
compar
healthi
subject
ms
ifnbtreat
ms
patient
ubiquitin
c
ubc
gene
best
normal
across
cell
subset
addit
also
identifi
best
combin
two
refer
gene
normal
either
control
ms
group
hprt
control
ms
ifnbtreat
ms
group
ubc
tyrosin
activ
protein
zetapolypeptid
ywhaz
noteworthi
refer
gene
show
high
variabl
express
consid
singl
normal
might
optim
combin
refer
gene
clear
studi
experiment
condit
lead
identif
differ
refer
gene
refer
gene
stabli
express
whole
blood
subject
affect
specif
patholog
may
highli
variabl
subject
differ
condit
henc
necessari
valid
appropri
refer
gene
specif
experiment
set
despit
time
consum
cost
bear
might
problem
normal
gain
interest
also
context
clinic
test
infecti
diseas
correctli
diagnos
pathogen
infect
crucial
precis
detect
presenc
infecti
agent
correspond
antibodi
trigger
immun
respons
incorrect
diagnosi
lead
wrongli
appli
therapeut
strategi
patient
well
enorm
risk
term
patient
life
cost
implement
rtqpcr
reliabl
quantif
viral
load
clinic
specimen
requir
normal
defin
standard
intern
control
diagnost
test
gener
base
titrat
sampl
extern
standard
curv
subject
ident
amplif
step
differ
sampl
size
lead
alter
readout
shown
sampl
volum
blood
hiv
posit
patient
yield
extract
rna
significantli
higher
patient
less
advanc
immunosuppress
count
cellsml
compar
patient
advanc
immunosuppress
cellsml
make
imposs
comparison
two
group
base
process
sampl
volum
thu
diagnost
method
compar
quantif
viral
load
intern
standardnorm
need
problem
specif
highlight
jab
colleagu
develop
qpcrbase
protocol
quantif
epsteinebarr
viru
ebv
pbmc
transplant
patient
predict
paramet
posttranspl
lymphoprolif
disord
ptld
author
combin
coamplif
ebv
genom
creactiv
protein
dna
serv
intern
normal
actual
amount
viral
dna
show
protocol
without
normal
detect
ebv
copi
number
within
rang
control
group
ptld
patient
hand
normal
ptld
patient
show
higher
amount
viral
copi
number
compar
control
group
indic
introduc
normal
method
viru
detect
sensit
accuraci
assay
increas
recent
altern
method
normal
viral
rna
whole
blood
sampl
cattl
infect
bovin
viral
diarrhea
viru
bvdv
develop
spike
blood
sampl
extern
rna
viru
canin
enter
coronaviru
cecov
rna
extract
quantif
normal
rtqpcr
allow
detect
viru
day
postchalleng
viral
detect
tradit
protocol
viru
isol
infect
cell
cultur
detect
day
postchalleng
even
though
method
appli
veterinari
strategi
could
success
appli
human
sampl
altogeth
rtqpcr
combin
normal
strategi
would
result
rapid
sensit
reliabl
detect
viral
infect
microrna
becom
increasingli
import
biomark
state
use
clinic
applic
limit
lack
standard
preanalyt
analyt
postanalyt
procedur
one
main
issu
concern
postanalyt
procedur
rtqpcr
data
normal
sinc
univers
approv
method
sever
normal
method
develop
use
normal
circul
mirna
lead
imposs
compar
result
differ
studi
common
strategi
use
normal
rtqpcr
data
base
exogen
synthet
oligonucleotid
geometr
mean
express
mirna
endogen
mirna
tabl
choic
refer
gene
crucial
aspect
rtqpcr
data
normal
order
avoid
erron
interpret
data
obtain
reliabl
biolog
result
priori
select
refer
gene
accord
one
report
literatur
repres
one
method
adopt
choos
intern
control
howev
precis
evalu
advis
sinc
express
potenti
refer
gene
could
chang
differ
experiment
condit
mathemat
model
genorm
normfind
bestkeep
compar
dct
develop
aim
identifi
stabl
endogen
mirna
use
normal
specif
experiment
condit
genorm
algorithm
select
stabl
intern
control
group
sampl
rank
gene
base
gene
stabil
paramet
calcul
averag
pairwis
variat
standard
deviat
logarithm
transform
express
ratio
potenti
refer
gene
other
gene
lower
valu
stepwis
exclus
repres
stabl
gene
normfind
algorithm
enabl
estim
intergroup
intragroup
variat
combin
two
variat
stabil
valu
calcul
potenti
refer
gene
rank
gene
stabil
valu
moreov
calcul
accumul
standard
deviat
accsd
indic
number
gene
use
normal
bestkeep
perform
descript
statist
analysi
cq
calcul
geometr
arithmet
mean
standard
deviat
coeffici
varianc
analyz
potenti
refer
gene
furthermor
perform
celmir
caenorabd
elegan
mirna
hsamirhaslet
homo
sapien
mirna
simian
viru
mmumir
mu
musculu
mirna
rnu
small
nucleolar
rna
pairwis
correl
analysi
pair
candid
gene
calcul
geometr
mean
best
suit
one
defin
optim
refer
gene
compar
dct
method
base
ct
comparison
pair
gene
base
dct
trend
gene
constant
variabl
among
analyz
sampl
possibl
identifi
stabl
gene
develop
algorithm
normfind
genorm
bestkeep
compar
dct
abl
identifi
stabl
gene
specif
experiment
set
facilit
delin
optim
refer
gene
normal
rtqpcr
data
howev
wide
heterogen
normal
method
lack
guidelin
identif
refer
gene
may
lead
erron
interpret
rtqpcr
data
differ
normal
strategi
concern
issu
discuss
synthet
oligonucleotid
caenorabd
elegan
mirna
simian
viru
gene
murin
nonhuman
sequenc
often
use
assess
effici
rna
process
rna
qualiti
ad
biolog
sampl
known
concentr
either
rna
isol
rna
reversetranscript
order
monitor
process
last
year
sinc
univers
accept
method
normal
circul
mirna
exist
exogen
synthet
oligonucleotid
also
use
mirna
quantif
use
singl
refer
gene
normal
mirna
wang
et
al
use
quantifi
serum
mirna
earli
detect
lung
cancer
anoth
studi
yang
et
al
use
refer
gene
determin
potenti
use
biomark
gastric
cancer
also
use
circul
mirna
normal
ho
et
al
use
normal
express
level
plasma
pancreat
cancer
patient
studi
rtqpcr
data
normal
base
averag
synthet
oligonucleotid
averag
use
exampl
normal
serumplasma
mirna
level
prostat
cancer
patient
although
synthet
oligonucleotidesbas
normal
strategi
adopt
use
impli
limit
circul
mirna
use
biomark
subject
set
preanalyt
variabl
includ
qualiti
amount
start
sampl
collect
modal
storag
condit
effici
mirna
isol
reversetranscript
may
contribut
alter
total
mirna
level
synthet
oligonucleotid
ad
mirna
isol
reversetranscript
subject
process
endogen
mirna
target
regard
rna
extract
pcr
howev
technic
variabl
gener
process
normal
synthet
oligonucleotid
overcom
problem
sourvin
et
al
adopt
strategi
normal
combin
synthet
oligonucleotid
endogen
gene
use
quantifi
healthi
small
cell
lung
carcinoma
patient
demonstr
differ
mirna
recoveri
cdna
synthesi
sampl
compens
refer
gene
consid
optim
normal
affect
variabl
target
mirna
endogen
gene
hold
prerequisit
sever
normal
strategi
base
endogen
refer
gene
develop
small
nucleolar
rna
rnu
ribosom
rna
rrna
wide
use
normal
circul
mirna
rtqpcr
analys
howev
noncod
rna
reflect
biolog
properti
mirna
sever
studi
shown
instabl
variabl
serum
plasma
differ
experiment
condit
concern
circul
mirna
huang
et
al
investig
potenti
role
intern
control
plasma
mirna
quantif
colorect
neoplasia
patient
demonstr
lower
stabil
less
abund
mirna
also
found
variabl
serum
healthi
volunt
patient
critic
ill
patient
liver
fibrosi
indic
inappropri
refer
gene
normal
circul
mirna
find
suggest
use
smallnon
code
rna
recommend
rtqpcr
data
normal
could
introduc
bias
mirna
quantif
normal
base
endogen
mirna
repres
suitabl
method
rtqpcr
data
analys
strategi
base
singl
mirna
multipl
mirna
develop
one
mostli
often
use
refer
gene
lawri
et
al
use
normal
mirna
quantif
serum
healthi
subject
larg
bcell
lymphoma
patient
anoth
studi
wong
et
al
use
quantifi
plasma
tongu
squamou
cell
carcinoma
patient
although
studi
found
compar
express
serumplasma
healthi
subject
cancer
patient
studi
highlight
instead
high
variabl
express
serumplasma
case
control
patient
analys
stabil
reveal
express
variabl
serum
differ
cancer
patient
exampl
found
upregul
breast
cancer
pancreat
cancer
patient
compar
control
furthermor
use
mirna
quantif
reconsid
sinc
found
suscept
hemolysi
analys
plasma
mirna
demonstr
upregul
haemolyz
plasma
therefor
mirna
evalu
potenti
refer
gene
studi
circul
mirna
serum
ovarian
cancer
patient
resnick
et
al
use
normal
rtqpcr
data
hu
et
al
identifi
potenti
endogen
refer
gene
circul
mirna
cancer
patient
analys
express
stabil
patient
eight
differ
cancer
type
three
control
subject
elsewher
use
refer
gene
quantif
serum
mirna
primari
biliari
cirrhosi
hepatocellular
carcinoma
patient
use
normal
serum
mirna
patient
inflammatori
bowel
diseas
hao
colleagu
use
normal
serum
mirna
multipl
myeloma
patient
use
intern
control
quantifi
mirna
associ
late
stage
neovascular
agerel
macular
degener
demonstr
use
multipl
refer
gene
rtqpcr
data
analys
reduc
effect
analyt
variabl
compar
singl
genebas
normal
mcdermott
et
al
studi
breast
cancer
patient
demonstr
combin
identifi
genorm
stabl
mirna
suitabl
use
mirna
alon
normal
rtqpcr
data
sever
studi
circul
mirna
adopt
normal
strategi
base
multipl
refer
gene
mirna
quantif
recent
studi
danes
et
al
combin
identifi
best
refer
normal
rtqpcr
mirna
analysi
colorect
adenocarcinoma
exosom
plasma
tissu
sampl
two
mirna
select
among
six
potenti
refer
gene
base
stabil
assess
trough
normfind
bestkeep
algorithm
song
et
al
studi
serum
mirna
gastric
cancer
patient
identifi
refer
gene
studi
combin
differ
algorithm
genorm
normfind
bestkeep
compar
dct
employ
identifi
best
refer
gene
among
preselect
mirna
small
nucleolar
rna
similar
approach
adopt
tang
et
al
use
reffind
softwar
integr
genorm
normfind
bestkeep
compar
dct
algorithm
identifi
suitabl
refer
gene
plasma
patient
hepatocellular
carcinoma
among
wang
et
al
demonstr
combin
gave
reliabl
result
quantif
serum
bladder
cancer
patient
two
mirna
select
genorm
normfind
stabil
among
set
five
potenti
refer
gene
genorm
normfind
also
employ
investig
set
refer
gene
analyz
exosomeassoci
mirna
serum
patient
hepat
b
hepatocellular
carcinoma
two
algorithm
identifi
combin
optim
refer
gene
normal
liverderiv
mirna
recent
studi
fractur
riskassoci
mirna
use
refer
gene
accord
priori
analysi
anoth
endogen
genebas
normal
method
repres
averag
express
valu
analyz
mirna
method
gener
use
experi
assay
larg
number
mirna
andor
experi
priori
select
refer
gene
absent
mestdagh
et
al
compar
normal
mean
express
mirna
stabl
small
rna
control
mirnasmal
rna
control
resembl
mean
express
valu
demonstr
mean
express
mirna
appropri
method
normal
larg
amount
data
biomark
especi
circul
mirna
emerg
import
clinic
diagnost
method
reliabl
detect
molecul
necessari
univoc
diagnos
pathophysiolog
condit
rtqpcr
extrem
sensit
accur
method
quantifi
circul
mirna
great
limit
implement
techniqu
clinic
repres
lack
standard
normal
methodolog
normal
rtqpcr
data
methodolog
requir
reduc
technic
bia
introduc
entir
experiment
process
choic
appropri
method
crucial
import
obtain
reliabl
biolog
result
sever
normal
method
develop
use
exogen
oligonucleotid
use
differ
endogen
refer
gene
heterogen
normal
strategi
use
differ
refer
gene
lead
inaccur
quantif
circul
mirna
possibl
misinterpret
result
differ
studi
sinc
still
possibl
defin
univers
accept
refer
gene
circul
mirna
quantif
advis
focu
standard
normal
method
select
casespecif
refer
gene
clear
corrobor
strategi
normal
identifi
valid
stabl
mirna
experiment
set
select
refer
gene
furthermor
case
larg
amount
data
besid
select
stabl
gene
also
accept
use
global
mean
inde
panel
mirna
normal
stabl
gene
mirna
use
refer
gene
longer
consider
target
great
advantag
normal
global
mean
consid
analyz
mirna
target
gene
draw
specif
guidelin
use
differ
normal
method
togeth
draw
standard
preanalyt
analyt
procedur
may
ensur
reproduc
result
possibl
compar
mirna
express
level
differ
studi
use
mirna
clinic
applic
